Table 3 shows that no significant factors contributed to stroke within 6 months in the Mo.Ma group. The other characteristics were not associated with outcomes of interest, including successful procedure, in-hospital mortality, and mortality within 6 months (data not shown). Because the serum albumin concentrations were similar (p = 0.825) in the filter group (3.56 ± 0.39) and Mo.Ma group (3.55 ± 0.33), there were no potential confounding factors in further outcomes of interest comparison between these two groups. The gene discussed is ALB; the disease is Stroke.